SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol. 2005;84:112.
  • 2
    Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res. 1992;52(19 suppl):5566s5569s.
  • 3
    Flowers CR, Sinha R, Vose JM. Improving outcomes for patients with diffuse large B-cell lymphoma. CA Cancer J Clin. 2010;60:393408.
  • 4
    De Roos AJ, Davis S, Colt JS, et al. Residential proximity to industrial facilities and risk of non-Hodgkin lymphoma. Environ Res. 2010;110:7078.
  • 5
    Smith MT. Advances in understanding benzene health effects and susceptibility. Annu Rev Public Health. 2010;31:133148.
  • 6
    Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine—National Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89:10651071.
  • 7
    Rinsky RA, Hornung RW, Silver SR, Tseng CY. Benzene exposure and hematopoietic mortality: a long-term epidemiologic risk assessment. Am J Ind Med. 2002;42:474480.
  • 8
    Kipen HM, Cody RP, Crump KS, Allen BC, Goldstein BD. Hematologic effects of benzene: a thirty-5 year longitudinal study of rubber workers. Toxicol Ind Health. 1988;4:411430.
  • 9
    Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007;67:876880.
  • 10
    Environmental Protection Agency. The Toxics Release Inventory (TRI) and Factors to Consider When Using TRI Data. Available at: http://www.epa.gov/tri/triprogram/FactorsToConPDF.pdf. Accessed March 22, 2012.
  • 11
    US Census Bureau. Introduction to Census 2000 Data Products. Available at: http://www.census.gov/prod/2001pubs/mso-01icdp.pdf. Accessed March 22, 2012.
  • 12
    Flowers C, Fedewa S, Chen A, et al. Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States. Cancer Epidemiol Biomarkers Prev. 2012;21:15201430.
  • 13
    Abouyabis AN, Shenoy PJ, Lechowicz MJ, Flowers CR. Incidence and outcomes of the peripheral T-cell lymphoma subtypes in the United States. Leuk Lymphoma. 2008;49:20992107.
  • 14
    Shenoy P, Maggioncalda A, Malik N, Flowers CR. Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States [serial online]. Adv Hematol 2011;2011:725219.
  • 15
    Shenoy P, Malik N, Sinha R, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011;11:498506.
  • 16
    Shenoy PJ, Malik N, Nooka A, et al. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States [published online ahead of print December 22, 2010]. Cancer. 2010.
  • 17
    Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 13 Registries Research Data, November 2010 Submission (1973-2008) <Katrina/Rita Population Adjustment> Linked to County Attributes—Total US Bethesda, MD: National Cancer Institute; 2009.
  • 18
    Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695708.
  • 19
    Environmental Systems Research Institute [ESRI]. Common questions. Available at: http://www.esri.com/software/coder/common-questions. Accessed January 9, 2012.
  • 20
    US Census Bureau. Census 2000 TIGER/Line Files: TIGER/Line Shapefiles and TIGER/Line Files. Available at: http://www.census.gov/geo/www/tiger/tiger2k/tgr2000.html. Accessed January 9, 2012.
  • 21
    Waller L, Gotway C. Applied Spatial Statistics for Public Health Data. New York: John Wiley & Sons, Inc.; 2004.
  • 22
    Kleinbaum D, Kupper L, Nizam A, Muller K. Applied Regression Analysis and Other Multivariable Methods. Pacific Grove, CA: Thomson Brooks/Cole; 2008.
  • 23
    Chang CM, Wang SS, Dave BJ, et al. Risk factors for non-Hodgkin lymphoma subtypes defined by histology and t(14;18) in a population-based case-control study. Int J Cancer. 2011;129:938947.
  • 24
    Ambinder AJ, Shenoy PJ, Malik N, Maggioncalda A, Nastoupil LJ, Flowers CR. Exploring risk factors for follicular lymphoma [serial online]. Adv Hematol 2012:626035, 2012.
  • 25
    Wallace LA. Major sources of benzene exposure. Environ Health Perspect. 1989;82:165169.
  • 26
    Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev. 2005;14:925933.
  • 27
    Brauner EV, Sorensen M, Gaudreau E, et al. A prospective study of organochlorines in adipose tissue and risk of non-Hodgkin lymphoma. Environ Health Perspect. 2012;120:105111.
  • 28
    The Environmental Integrity Project and the Galeston-Houstohn Association for Smog Prevention. Who's Counting? The Systematic Underreporting of Toxic Air Emissions. Washington, DC: US Environmental Protection Agency; 2004.
  • 29
    Smith MT, Jones RM, Smith AH. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:385391.
  • 30
    Cocco P, t'Mannetje A, Fadda D, et al. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med. 2010;67:341347.
  • 31
    Vlaanderen J, Lan Q, Kromhout H, Rothman N, Vermeulen R. Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating 3 study quality dimensions. Environ Health Perspect. 2011;119:159167.
  • 32
    Kane EV, Newton R. Benzene and the risk of non-Hodgkin lymphoma: a review and meta-analysis of the literature. Cancer Epidemiol. 2010;34:712.
  • 33
    Linos A, Blair A, Gibson RW, et al. Leukemia and non-Hodgkin's lymphoma and residential proximity to industrial plants. Arch Environ Health. 1991;46:7077.
  • 34
    Ramis R, Vidal E, Garcia-Perez J, et al. Study of non-Hodgkin's lymphoma mortality associated with industrial pollution in Spain, using Poisson models [serial online]. BMC Public Health. 2009;9:26.
  • 35
    Johnson KC, Pan S, Fry R, Mao Y. Residential proximity to industrial plants and non-Hodgkin lymphoma. Epidemiology. 2003;14:687693.
  • 36
    Ramis R, Diggle P, Boldo E, Garcia-Perez J, Fernandez-Navarro P, Lopez-Abente G. Analysis of matched geographical areas to study potential links between environmental exposure to oil refineries and non-Hodgkin lymphoma mortality in Spain [serial online]. Int J Health Geogr. 2012;11:4.
  • 37
    Viel JF, Floret N, Deconinck E, Focant JF, De Pauw E, Cahn JY. Increased risk of non-Hodgkin lymphoma and serum organochlorine concentrations among neighbors of a municipal solid waste incinerator. Environ Int. 2011;37:449453.
  • 38
    Wheeler DC, Ward MH, Waller LA. Spatial-temporal analysis of cancer risk in epidemiologic studies with residential histories [serial online]. Ann Assoc Am Geogr. 2012;102:10491057.
  • 39
    Dreiher J, Novack V, Barachana M, Yerushalmi R, Lugassy G, Shpilberg O. Non-Hodgkin's lymphoma and residential proximity to toxic industrial waste in southern Israel. Haematologica. 2005;90:17091710.
  • 40
    Dahlgren J, Klein J, Takhar H. Cluster of Hodgkin's lymphoma in residents near a non-operational petroleum refinery. Toxicol Ind Health. 2008;24:683692.